Paul Edward Kelly has bought RLMD on 6 days since Oct 2018
COO at Relmada Therapeutics, Inc.
SEC CIK 0001658544 · Filings on SEC.gov ↗
Paul Edward Kelly's record
3 months after each buy, from the first price a copier could get.
3 buys since 2018 with 3 months of prices.
Every filing
13 filings since Oct 2018, newest first
Relmada Therapeutics, Inc.
COO
Relmada Therapeutics, Inc.
COO
Relmada Therapeutics, Inc.
Director
Relmada Therapeutics, Inc.
Director
Relmada Therapeutics, Inc.
Director
Relmada Therapeutics, Inc.
Director
Relmada Therapeutics, Inc.
Director
Relmada Therapeutics, Inc.
Director
Relmada Therapeutics, Inc.
Director
Relmada Therapeutics, Inc.
Director
Relmada Therapeutics, Inc.
Director
Relmada Therapeutics, Inc.
Director
Relmada Therapeutics, Inc.
Director
About Paul Edward Kelly
Kelly Paul Edward serves as the Chief Operating Officer (COO) at Relmada Therapeutics, Inc. (RLMD), where they have recently engaged in insider trading activities. Their professional background includes executive leadership in the healthcare and life sciences sectors, with prior roles emphasizing operations, strategy, and supply chain management.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.